Search

Your search keyword '"Petrica L."' showing total 191 results

Search Constraints

Start Over You searched for: Author "Petrica L." Remove constraint Author: "Petrica L."
191 results on '"Petrica L."'

Search Results

1. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

4. Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis

5. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease: Results from the CREDENCE trial and meta-analysis

8. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

9. The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics

10. Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial

11. SP442THE TIME FRAME OF VASCULAR REMODELLING IS DISSOCIATED WITHIN THE BRAIN AND THE KIDNEY AND MAY BE EXPLAINED BY THE VARIABILITY OF miRNAs EXPRESSION IN TYPE 2 DIABETES MELLITUS PATIENTS

12. Cerebrolysin adjuvant treatment in Broca's aphasics following first acute ischemic stroke of the left middle cerebral artery

13. Cerebral Microangiopathy in Patients with Non-insulin-dependent Diabetes Mellitus

14. Glycated peptides are associated with proximal tubule dysfunction in type 2 diabetes mellitus

21. Glycated peptides induce endothelial dysfunction in the brain vasculature in normoalbuminuric patients with type 2 diabetes mellitus

29. Clinical Nephrology - Lab methods and other markers

30. Diabetes - Clinical

31. Progression & risk factors CKD 1-5 (2)

33. 105: Is There a Difference Between the Glomerular Filtration Rate (GFR) of Patients With HBV and HCV Chronic Hepatitis and Patients With C Cirrhosis?

37. PO03-MO-11 Does PPARγ-agonist rosiglitazone exert nephro- and neuroprotective effects in normoalbuminuric type 2 diabetes mellitus patients?

41. 67

47. Pioglitazone delays proximal tubule dysfunction and improves cerebral vessel endothelial dysfunction in normoalbuminuric people with type 2 diabetes mellitus.

Catalog

Books, media, physical & digital resources